Inhibition of CCAAT/Enhancer Binding Protein Family DNA Binding in Mouse Epidermis Prevents and Regresses Papillomas

February 2007 in “ Cancer Research ”

Won Jun Oh, Vikas Rishi, András Orosz, Michael J. Gerdes, Charles Vinson

CCAAT/enhancer binding proteins C/EBP A-C/EBP C/EBPβ C/EBPα p53 Bax caspase-3 apoptosis hyperplasia papillomas hair loss

Studysummary This study found that inhibiting C/EBP transcription factors in mouse skin reduced papilloma formation and caused systemic hair loss, suggesting C/EBP may be a potential therapeutic target. Our plain-language summary of this paper — not a Tressless recommendation.

The study investigated the role of the CCAAT/Enhancer Binding Protein (C/EBP) family in the development of papillomas in mouse epidermis. Researchers found that inhibiting the DNA binding activity of the C/EBP family in the epidermis of mice not only prevented the formation of papillomas but also led to the regression of existing papillomas. This suggested that the C/EBP family played a crucial role in the development and maintenance of papillomas, indicating potential therapeutic targets for preventing and treating such skin lesions.

View this study on aacrjournals.org →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Activator Protein-1 Activity Regulates Epithelial Tumor Cell Identity

70 citations , August 2006 in “Cancer Research”

This study found that inhibiting AP-1 activity in mice modified tumor development, leading to transdifferentiation between squamous and sebaceous tumors, with molecular analysis suggesting AP-1's role in maintaining tumor cell identity.

research Conditional Gene Expression in the Epidermis of Transgenic Mice Using the Tetracycline-Regulated Transactivators tTA and rTA Linked to the Keratin 5 Promoter

215 citations , November 2000 in “Journal of Investigative Dermatology”

This study found that the tetracycline-regulated transcription system effectively controls conditional gene expression in the mouse epidermis, allowing suppression and activation of specific genes with doxycycline.